v3 Template
S
Slate Medicines, Inc.
Biotechnology
Founded
--
Employees
--
Total Funding
$130.0M
Funding Rounds
1
Last Funding
2026-02-24
About Slate Medicines, Inc.
Slate Medicines is a biotechnology company dedicated to developing next-generation therapeutics targeting PACAP for the treatment and prevention of migraine and other headache disorders.
Products & Services
Next-Generation Therapeutics:Therapeutics targeting PACAP for the treatment and prevention of migraine and other headache disorders. (Coming Soon)
Specialties
Therapeutics for Migraine
Headache Disorder Treatments
PACAP Targeting
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Series A T: - FT: Series A |
A: 130000000 MR: - FA: $130 million FAN: 130000000 |
D: 2026-02-24 FD: 2026-02-24 |
4 investors |
Series A
Latest
2026-02-24
$130.0M
4 investors (Pro only)
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Slate Medicines, Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- slatemedicines.com
- Industries
- Biotechnology
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro